INFLUENCE OF INGARON UPON IMMUNE STATE OF THE PATIENTS WITH ADENOCARCINOMA OF LUNG IN THE COURSE OF ADJUVANT THERAPY

par S. P. Pyltsin, E. Yu. Zlatnik, Yu. N. Lazutin, G. Z. Sergostyants, G. I. Zakora, I. A. Leyman, P. A. Anistratov
Publié 2015

Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment

par Zheng D, Wan C, Yang H, Xu L, Dong Q, Du C, Du J, Li F
Publié 2020

Adaptive fuzzy controller design of drug dosage using optimal trajectories in a chemoimmunotherapy cancer treatment model

par Hossein Naderi, Mohammadmahdi Mehrabi, Mohammad Taghi Ahmadian
Publié 2021

Novel Multimodal Management of Post-Partum Synchronous Metastatic Pulmonary EBV-Associated Lymphoepithelioma-Like Carcinoma (LELC)—A Case Report

par Montserrat Pazos, Chukwuka Eze, Kathrin Kahnert, Maria Delius, Amanda Tufman, Irene Alba-Alejandre, Marcus Unterrainer, Jens Neumann, Thomas Kirchner, Farkhad Manapov
Publié 2021

Modern possibilities of immunotherapy in the treatment of extensive-stage small cell lung cancer: experience of durvalumab application. Case report

par Albina S. Zhabina, Fedor V. Moiseenko, Nikita M. Volkov, Nuriniso Kh. Abduloeva, Vladimir M. Moiseenko
Publié 2021